InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Curran Terrie, Chairman & CEO. Insider active across 3 companies, notably Myovant Sciences Ltd.. Aggregated, 9 filings have been recorded. Total volume traded: €146k. The latest transaction was filed on 1 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
04,312 shares0
Common Stock
SEC:0001567619-22-012323:0·
012,000 shares0
Common Stock
SEC:0001209191-22-031080:0·
€146,28320,500 shares@ €7.13570.015% mcap100.0% of flow
Common Stock
SEC:0001209191-22-029451:0·
Ideal exit: 7 Feb 2023 (T+270)
041,250 shares0
Common Stock
SEC:0001209191-22-004488·
041,250 shares0
Common Stock
SEC:0001209191-22-004488:0·
€31,3744,850 shares@ €6.468829.9% of flow
Common Shares
SEC:0001209191-21-055667·
€31,3744,850 shares@ €6.468815.0% of flow
Common Shares
SEC:0001209191-21-055667:0·
€73,47711,373 shares@ €6.460770.1% of flow
Common Shares
SEC:0001209191-21-054758·
€73,47711,373 shares@ €6.460735.0% of flow
Common Shares
SEC:0001209191-21-054758:0·
9 of 9 declarations
About Curran Terrie
Terrie Curran is President and Chief Executive Officer at Myovant Sciences Ltd., Phathom Pharmaceuticals, Inc., and Arcutis Biotherapeutics, Inc. She leads these companies with a focus on innovation and growth. Her leadership is essential for the development of new treatments.
